About AstraZeneca and AISIAt AstraZeneca, technology and science meet to change what is possible for patients. We are building a connected, end-to-end Enterprise AI engine that unites data foundations, AI technology, process reinvention, and business-facing AI to accelerate results across the whole value chain. Success depends on being an exceptional connector: you will leverage existing capabilities, promote reuse, share breakthrough ideas across geographies and functions, and focus on scaling impact rather than building in isolation.AI Science & Innovation (AISI) sits at the centre of AstraZeneca's R&D AI transformation. Our remit is to build, buy, and deliver the AI models and agents that change pipeline outcomes, across discovery, translational science, biomarkers, and clinical development.Within AISI, the BioPharma Clinical Development AI team is building world-class AI capability to accelerate the design, conduct, and analysis of clinical trials across our BioPharmaceuticals pipeline, in both early and late phase programmes. We partner closely with clinical development, regulatory, and biometrics teams to bring better treatments to patients faster, while adhering to the highest evidentiary standards.The OpportunityClinical development is one of the most data-rich and decision-intensive parts of bringing a new medicine to patients. Trial design, patient selection, dose optimisation, biomarker strategy, and safety evaluation are all areas where AI and machine learning can add rigour, speed, and precision, as a powerful complement to clinical and statistical expertise.You will work in cross-functional teams across the key BioPharmaceuticals disease areas of cardiovascular, renal, metabolic disease, respiratory, and immunology. Alongside experienced data scien…StatistikerStatistiker
Jobbfinder